PAK5 rs11086694: Understanding Its Association With Alzheimer's Risk

What each genotype means

What is rs11086694?

The rs11086694 variant is a specific genetic change, known as a single nucleotide polymorphism (SNP), located within the PAK5 gene. In genomics, a SNP represents a variation at a single position in the DNA sequence among individuals. This particular variant has been identified in studies investigating the genetic architecture of complex neurological conditions. Because it sits within the PAK5 gene, researchers are interested in how this variation might alter the gene's function or expression levels. While the exact biological mechanism by which this specific SNP exerts an effect is still being explored, its location in a gene involved in neuronal health makes it a subject of ongoing scientific inquiry.

The Role of the PAK5 Gene

The PAK5 gene encodes a protein belonging to the p21-activated kinase (PAK) family, which plays a critical role in regulating the neuronal cytoskeleton. PAK5 is known to influence the stability of microtubules and the dynamics of actin, which are essential for maintaining the structure and function of neurons. Specifically, PAK5 has been shown to interact with and inhibit MARK2, a kinase that phosphorylates the Tau protein. In healthy neurons, Tau helps stabilize microtubules, but in conditions like Alzheimer's disease, Tau can become hyperphosphorylated and detach from these structures. By regulating the kinases that control Tau, PAK5 is thought to be a key player in maintaining the integrity of axonal transport and overall neuronal health.

Research and Evidence Strength

The association between rs11086694 and Alzheimer's disease is considered to have moderate evidence strength. Recent studies, including those utilizing advanced statistical methods like LASSO regression and conditional selective inference, have identified this variant as a potential factor in the risk of Alzheimer's disease and mild cognitive impairment. These findings point toward a potential pathway involving the PAK5 gene and the Tau protein hypothesis, which is a well-established area of Alzheimer's research. However, it is important to note that genetic associations are statistical in nature and do not imply a direct cause-and-effect relationship. Further research is required to fully understand the functional impact of this variant and how it contributes to disease risk across different populations.

Population Frequency

Currently, there is no widely available, definitive data regarding the population frequency of the rs11086694 variant across different ancestral groups. Genetic databases often lack comprehensive frequency information for many variants until they are studied in large, diverse cohorts. As a result, it is unknown how common this variant is in the general population or if its frequency varies significantly between different ethnic or geographic groups. Researchers continue to collect data to better understand the distribution of such variants, which is essential for determining their clinical relevance and potential utility in risk assessment models.

Interpreting Genetic Information

It is important to understand that having a specific genotype for rs11086694 does not constitute a medical diagnosis. Genetic variants associated with complex diseases like Alzheimer's represent only one piece of a much larger puzzle that includes environmental factors, lifestyle, and other genetic influences. This information should not be used to make personal health decisions or to predict individual outcomes. If you are concerned about your cognitive health or family history, the most appropriate step is to consult with a qualified healthcare professional or a genetic counselor. They can provide context based on your personal health history and guide you through the complexities of genetic testing and risk assessment.

Frequently asked questions

Sources & further reading

Related variants in PAK5